Amélie Boulais Raveneau

Amélie Boulais Raveneau has extensive work experience in the biotech industry. Amélie started their career as an intern at Extraits d'Anjou in 2006. In 2007, they interned at Sartorius Stedim Biotech before being hired as an Application Specialist in Purification Technologies in 2008. Amélie worked in this role until 2010 when they became an Application Specialist in Purification Technologies. In 2013, they became a Membrane Chromatography and Virus Clearance Project Manager and held this position until 2015. Amélie then became a Process Development Consultant from 2015 to 2016. From 2016 to 2020, they served as a Vaccine Platform Marketing Manager. Amélie then transitioned to the role of Market Entry Strategy Manager for Viral Based Therapeutics from 2020 to 2022 and later became the Head of Market Entry Strategy for the same division. Currently, they are the Manager of Market Entry Strategy for Separation Technologies.

Amélie Boulais Raveneau obtained a Master's Degree in Biotechnology from ENSTBB Bordeaux INP, where they studied from 2005 to 2008.